Comments
Loading...

Humacyte Analyst Ratings

HUMANASDAQ
Logo brought to you by Benzinga Data
$1.87
0.148.09%
At close: -
$1.90
0.031.60%
After Hours: 7:57 PM EDT
Q1 2025 Earnings were released on Tue May 13th, before the market open
The most recent conference call was at 8:30 AM, 1 day ago Click to view past webcast
Consensus Rating1
Buy
Highest Price Target1
$25.00
Lowest Price Target1
$3.00
Consensus Price Target1
$12.30

Humacyte Analyst Ratings and Price Targets | NASDAQ:HUMA | Benzinga

Humacyte Inc has a consensus price target of $12.3 based on the ratings of 10 analysts. The high is $25 issued by D. Boral Capital on May 13, 2025. The low is $3 issued by Piper Sandler on November 10, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Benchmark, and D. Boral Capital on May 14, 2025, May 14, 2025, and May 13, 2025, respectively. With an average price target of $14.33 between HC Wainwright & Co., Benchmark, and D. Boral Capital, there's an implied 654.39% upside for Humacyte Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Jan
3
Feb
5
Mar
3
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Benchmark
D. Boral Capital
HC Wainwright & Co.
EF Hutton

1calculated from analyst ratings

Analyst Ratings for Humacyte

Buy NowGet Alert
05/14/2025Buy Now110.53%HC Wainwright & Co.
Swayampakula Ramakanth52%
→ $4Assumes → BuyGet Alert
05/14/2025Buy Now636.84%Benchmark
Bruce Jackson39%
$17 → $14MaintainsBuyGet Alert
05/13/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
03/31/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
03/28/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
03/26/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
03/12/2025Buy Now689.47%HC Wainwright & Co.
Vernon Bernardino48%
$15 → $15ReiteratesBuy → BuyGet Alert
03/07/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
02/27/2025Buy NowBenchmark
Bruce Jackson39%
ReiteratesBuy → BuyGet Alert
02/27/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
02/26/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
01/21/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
01/13/2025Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
12/23/2024Buy Now794.74%Benchmark
Bruce Jackson39%
$15 → $17MaintainsBuyGet Alert
12/20/2024Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
12/20/2024Buy Now689.47%HC Wainwright & Co.
Vernon Bernardino48%
$12 → $15ReiteratesBuy → BuyGet Alert
11/21/2024Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
11/18/2024Buy Now531.58%HC Wainwright & Co.
Vernon Bernardino48%
$12 → $12ReiteratesBuy → BuyGet Alert
11/13/2024Buy Now531.58%HC Wainwright & Co.
Vernon Bernardino48%
$12 → $12ReiteratesBuy → BuyGet Alert
11/11/2024Buy Now1215.79%D. Boral Capital
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
11/05/2024Buy Now531.58%HC Wainwright & Co.
Vernon Bernardino48%
$6 → $12MaintainsBuyGet Alert
10/28/2024Buy Now1215.79%EF Hutton
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
10/18/2024Buy Now426.32%TD Cowen
Joshua Jennings55%
$10 → $10ReiteratesBuy → BuyGet Alert
10/18/2024Buy Now426.32%BTIG
Ryan Zimmerman71%
$10 → $10ReiteratesBuy → BuyGet Alert
10/10/2024Buy Now689.47%Benchmark
Bruce Jackson39%
$15 → $15ReiteratesBuy → BuyGet Alert
10/01/2024Buy Now1215.79%EF Hutton
Jason Kolbert43%
$25 → $25MaintainsBuyGet Alert
09/20/2024Buy Now584.21%Cantor Fitzgerald
Kristen Kluska67%
$13 → $13ReiteratesOverweight → OverweightGet Alert
09/09/2024Buy Now1215.79%EF Hutton
Jason Kolbert43%
→ $25Initiates → BuyGet Alert
09/05/2024Buy Now689.47%Benchmark
Bruce Jackson39%
$15 → $15ReiteratesBuy → BuyGet Alert
08/14/2024Buy Now689.47%Benchmark
Bruce Jackson39%
$15 → $15ReiteratesBuy → BuyGet Alert
08/12/2024Buy Now689.47%Benchmark
Bruce Jackson39%
$15 → $15ReiteratesBuy → BuyGet Alert
07/15/2024Buy Now478.95%BTIG
Ryan Zimmerman71%
$8 → $11MaintainsBuyGet Alert
07/02/2024Buy Now268.42%Cantor Fitzgerald
Kristen Kluska67%
$7 → $7ReiteratesOverweight → OverweightGet Alert
07/02/2024Buy Now689.47%Benchmark
Bruce Jackson39%
$15 → $15ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now689.47%Benchmark
Bruce Jackson39%
$15 → $15ReiteratesBuy → BuyGet Alert
05/13/2024Buy Now689.47%Benchmark
Bruce Jackson39%
$15 → $15ReiteratesBuy → BuyGet Alert
04/01/2024Buy Now268.42%Cantor Fitzgerald
Kristen Kluska67%
$7 → $7ReiteratesOverweight → OverweightGet Alert
03/26/2024Buy Now110.53%Piper Sandler
Allison Bratzel63%
$4 → $4MaintainsNeutralGet Alert
03/25/2024Buy Now689.47%Benchmark
Bruce Jackson39%
$15 → $15ReiteratesBuy → BuyGet Alert
03/08/2024Buy Now110.53%Piper Sandler
Allison Bratzel63%
$3 → $4MaintainsNeutralGet Alert
12/27/2023Buy Now689.47%Benchmark
Bruce Jackson39%
$16 → $15MaintainsBuyGet Alert
12/11/2023Buy Now215.79%HC Wainwright & Co.
Vernon Bernardino48%
→ $6Initiates → BuyGet Alert
11/10/2023Buy Now57.89%Piper Sandler
Matt O'Brien52%
$3.5 → $3MaintainsNeutralGet Alert
09/21/2023Buy Now268.42%Cantor Fitzgerald
Kristen Kluska67%
→ $7ReiteratesOverweight → OverweightGet Alert
08/31/2023Buy Now215.79%Cantor Fitzgerald
Kristen Kluska67%
→ $6ReiteratesOverweight → OverweightGet Alert
08/24/2023Buy Now215.79%Cantor Fitzgerald
Kristen Kluska67%
→ $6ReiteratesOverweight → OverweightGet Alert
08/15/2023Buy Now742.11%Benchmark
Bruce Jackson39%
→ $16ReiteratesBuy → BuyGet Alert
06/22/2023Buy Now215.79%Cantor Fitzgerald
Kristen Kluska67%
→ $6Initiates → OverweightGet Alert
06/12/2023Buy Now742.11%Benchmark
Bruce Jackson39%
→ $16ReiteratesBuy → BuyGet Alert
03/27/2023Buy Now742.11%Benchmark
Bruce Jackson39%
→ $16Reiterates → BuyGet Alert
07/18/2022Buy Now426.32%BTIG
Ryan Zimmerman71%
$12 → $10MaintainsBuyGet Alert

FAQ

Q

What is the target price for Humacyte (HUMA) stock?

A

The latest price target for Humacyte (NASDAQ:HUMA) was reported by HC Wainwright & Co. on May 14, 2025. The analyst firm set a price target for $4.00 expecting HUMA to rise to within 12 months (a possible 110.53% upside). 35 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Humacyte (HUMA)?

A

The latest analyst rating for Humacyte (NASDAQ:HUMA) was provided by HC Wainwright & Co., and Humacyte their buy rating.

Q

When was the last upgrade for Humacyte (HUMA)?

A

There is no last upgrade for Humacyte

Q

When was the last downgrade for Humacyte (HUMA)?

A

There is no last downgrade for Humacyte.

Q

When is the next analyst rating going to be posted or updated for Humacyte (HUMA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humacyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humacyte was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.

Q

Is the Analyst Rating Humacyte (HUMA) correct?

A

While ratings are subjective and will change, the latest Humacyte (HUMA) rating was a with a price target of $0.00 to $4.00. The current price Humacyte (HUMA) is trading at is $1.90, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch